Related Experiment Video
Updated: Oct 7, 2025
06:15
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
1.1K
Viral infections in lung transplantation
Aline Munting1, Oriol Manuel1,2
1Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.
Journal of Thoracic Disease
|January 7, 2022
Summary
Viral infections significantly impact lung transplant recipients, causing complications and allograft dysfunction. Effective management and new strategies are crucial for improving survival and quality of life in these patients.
Area of Science:
- Infectious diseases and transplantation immunology.
Background:
- Viral infections are a major cause of complications, morbidity, and mortality in lung transplant recipients, contributing up to 30% of infectious issues.
- Viral replication and immune responses can lead to lung injury, acute rejection, and chronic lung allograft dysfunction, particularly from herpesviruses and respiratory viruses.
Purpose of the Study:
- To review the impact of viral infections on lung transplant recipients.
- To discuss current management strategies and the need for new therapeutic and preventive approaches for various viral infections.
Main Methods:
- Review of existing literature on viral infections in lung transplant recipients.
- Analysis of the impact of viral infections on allograft outcomes.
- Evaluation of current and emerging antiviral therapies and preventive measures.
Main Results:
- Preventive measures for cytomegalovirus (CMV) and influenza, along with early antiviral treatment, have reduced disease burden and improved allograft outcomes.
- New antivirals for CMV prophylaxis and resistant infections are under evaluation.
- Significant unmet needs exist for respiratory syncytial virus (RSV), parainfluenza virus (PIV), and COVID-19 management in this population.
Conclusions:
- Appropriate management of viral complications is essential for improving survival and quality of life in lung transplant recipients.
- Continued development of novel antiviral and vaccine strategies is necessary for managing a broader range of viral pathogens.
- Further research is needed to optimize treatment regimens, particularly for COVID-19 in lung transplant recipients.
Related Concept Videos
01:30Pneumonia I: Introduction
384
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
384
01:29Pulmonary Tuberculosis I
388
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
388
01:28Kidney Transplant I: Introduction
70
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
70